Brain organoids and assembloids are opening new opportunities to investigate the complexity of neural development, organization, and function. These advanced experimental systems offer unprecedented possibilities to study human-specific developmental processes, uncover mechanisms underlying neurological disorders, and bridge the gap between traditional laboratory models and human biology.
Organized by Prof. Guo-li Ming (University of Pennsylvania) and Prof. Sergiu Pașca (Stanford University), the fifth edition of this conference will foster scientific exchange across disciplines, highlighting emerging discoveries in human brain development, evolution, and disease. Through keynote presentations, scientific sessions, and discussions, participants will explore how advances in stem cell biology, bioengineering, and 3D neural models are transforming our ability to investigate the developing human brain and model neurological conditions.
At MaxWell Biosystems, we are excited to be part of this scientific community and contribute to the advancement of human-relevant neuroscience research. Our High-Density Microelectrode Array (HD-MEA) technology enables researchers to investigate the functional properties of neuronal networks with high spatial and temporal resolution, providing valuable insights into neuronal activity, network dynamics, and functional connectivity.
We look forward to connecting with researchers at CSHL 2026, exchanging ideas, and exploring how innovative technologies and interdisciplinary collaborations can help unlock new insights into human brain development and disease.

Meet us at booth number 18. Stop by to meet the MaxWell Biosystems team, exchange ideas, and discover how next-generation HD-MEA technology is advancing our understanding of neuronal function and supporting new approaches to neuroscience research, disease modeling, and drug discovery.